year 11, Issue 3 (Autumn 2023)
Ann Appl Sport Sci 2023, 11(3): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tayebi S M, Eslami R, Iranshad I, Golmohammadi M. The Effect of Eight Weeks of Circuit Resistance Training on Serum Levels of GPR119 and β-Arrestin1 in Individuals with Type 2 Diabetes. Ann Appl Sport Sci 2023; 11 (3)
URL: http://aassjournal.com/article-1-1283-en.html
URL: http://aassjournal.com/article-1-1283-en.html
1- Department of Sports Physiology, Faculty of Sports Sciences, Allameh Tabataba'i University, Tehran, Iran , tayebism@atu.ac.ir
2- Department of Sports Physiology, Faculty of Sports Sciences, Allameh Tabataba'i University, Tehran, Iran
2- Department of Sports Physiology, Faculty of Sports Sciences, Allameh Tabataba'i University, Tehran, Iran
Abstract: (623 Views)
Background. The rising prevalence of diabetes has elevated its status as a significant health concern. Diabetes is a metabolic disorder characterized by elevated blood glucose levels, leading to various pathological changes such as neuropathy, nephropathy, retinopathy, gastrointestinal disorders, immune system impairment, vascular damage, and impaired tissue regeneration.
Objectives. This study aimed to examine the effects of eight weeks of circuit resistance training (CRT) on serum levels of GPR119 and β-Arrestin1 in individuals with type 2 diabetes.
Methods. Twenty male persons with type 2 diabetes (T2DM), who visited the diabetes clinic in Towhid Hospital and the Diabetes Association of Sanandaj city, were randomly divided into two groups: a control group (n=10) and an experimental group (n=10). CRT was conducted for eight weeks (three non-consecutive sessions per week). The exercise program consisted of gradually increasing sets, intensity, and volume, starting from 2 sets at 40% of 1RM (15 repetitions) in the initial sessions, and progressing to 4 sets at 80% of 1RM (6 repetitions) in the final sessions. Rest intervals of 20 to 30 seconds between sets and 3 minutes between rounds were implemented. GPR119 and β-Arrestin1 levels were assessed via ELISA method.
Results. Repeated measures analysis of variance revealed that CRT significantly increased GPR119 and β-Arrestin1 levels in the experimental group (p=0.023 and p=0.032, respectively).
Conclusion. Based on the reduction of insulin resistance (IR) in the persons with persons with T2DM in adaptation with CRT, and the roles of GPR119 and β-Arrestin1 in IR, the therapeutic implications of CRT via these proteins may be expected.
Objectives. This study aimed to examine the effects of eight weeks of circuit resistance training (CRT) on serum levels of GPR119 and β-Arrestin1 in individuals with type 2 diabetes.
Methods. Twenty male persons with type 2 diabetes (T2DM), who visited the diabetes clinic in Towhid Hospital and the Diabetes Association of Sanandaj city, were randomly divided into two groups: a control group (n=10) and an experimental group (n=10). CRT was conducted for eight weeks (three non-consecutive sessions per week). The exercise program consisted of gradually increasing sets, intensity, and volume, starting from 2 sets at 40% of 1RM (15 repetitions) in the initial sessions, and progressing to 4 sets at 80% of 1RM (6 repetitions) in the final sessions. Rest intervals of 20 to 30 seconds between sets and 3 minutes between rounds were implemented. GPR119 and β-Arrestin1 levels were assessed via ELISA method.
Results. Repeated measures analysis of variance revealed that CRT significantly increased GPR119 and β-Arrestin1 levels in the experimental group (p=0.023 and p=0.032, respectively).
Conclusion. Based on the reduction of insulin resistance (IR) in the persons with persons with T2DM in adaptation with CRT, and the roles of GPR119 and β-Arrestin1 in IR, the therapeutic implications of CRT via these proteins may be expected.
Keywords: Resistance Training, Type 2 Diabetes, GPR119, Β-Arrestin1, Insulin Resistance, Insulin Sensivity
Full-Text [PDF 845 kb]
(207 Downloads)
APPLICABLE REMARKS
APPLICABLE REMARKS
- Circuit resistance training (at least 8 weeks, 3 sessions/week) with low to moderate intensity prescribed for the reduction of fasting blood glucose and insulin resistance of men with T2DM and without retinopathy, neuropathy, nephropathy, and etc.
Type of Study: Original Article |
Subject:
Sport Physiology and its related branches
Received: 2023/08/15 | Accepted: 2023/11/1
Received: 2023/08/15 | Accepted: 2023/11/1
References
1. Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol. 2011;10(1):12. [DOI:10.1186/1475-2840-10-12] [PMID] [PMCID]
2. Zhu X, Huang W, Qian H. GPR119 agonists: a novel strategy for type 2 diabetes treatment. Diabetes mellitus-insights perspectives. 2013. [DOI:10.5772/48444]
3. Tayebi SM, Golmohammadi M, Eslami R, Shakiba N, Costa PB. The Effects of Eight Weeks of Circuit Resistance Training on Serum METRNL Levels and Insulin Resistance in Individuals with Type 2 Diabetes. Journal of Diabetes & Metabolic Disorders. 2023. [DOI:10.1007/s40200-023-01225-1]
4. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19-39.
5. Kobilka BK. G protein coupled receptor structure and activation. Biochim Biophys Acta. 2007;1768(4):794-807. [DOI:10.1016/j.bbamem.2006.10.021] [PMID] [PMCID]
6. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008;7(4):339-57. [DOI:10.1038/nrd2518] [PMID]
7. Hauser AS, Attwood MM, Rask-Andersen M, Schioth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017;16(12):829-42. [DOI:10.1038/nrd.2017.178] [PMID] [PMCID]
8. Overton HA, Fyfe MC, Reynet C. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br J Pharmacol. 2008;153 Suppl 1(Suppl 1):S76-81. [DOI:10.1038/sj.bjp.0707529] [PMID] [PMCID]
9. Feng X, Wang W, Liu J, Liu Y. beta-Arrestins: multifunctional signaling adaptors in type 2 diabetes. Mol Biol Rep. 2011;38(4):2517-28. [DOI:10.1007/s11033-010-0389-3] [PMID]
10. Saeidi A, Hackney AC, Tayebi SM, Ahmadian M, Zouhal H. Diabetes, Insulin Resistance, Fetuin-B and Exercise Training. Annals of Applied Sport Science. 2019;7(2):1-2. [DOI:10.29252/aassjournal.7.2.1] [PMID] [PMCID]
11. Saeidi A, Tayebi SM, Khosravi A, Malekian F, Khodamoradi A, Sellami M, et al. Effects of exercise training on type 2-diabetes: the role of Meteorin-like protein. Health Promot Perspect. 2019;9(2):89-91. [DOI:10.15171/hpp.2019.12] [PMID] [PMCID]
12. Saeidi A, Tayebi SM, Khosravi A, Razi O, Sellami M, Abderrahman AB, Zouhal H. Obesity, Fat Mass, Osteopontin and Exercise Training. International Journal of Applied Exercise Physiology. 2019;8(1):177-9.
13. Tayebi SM, Ghanbari-Niaki A, Saeidi A, Hackney AC. Exercise Training, Neuregulin 4 and Obesity. Ann Appl Sport Sci. 2017;5(2):1-2. [DOI:10.18869/acadpub.aassjournal.5.2.1] [PMID] [PMCID]
14. Schönke M, Martinez-Tellez B, Rensen PC. Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise. Curr Opin Pharmacol. 2020;52:52-60. [DOI:10.1016/j.coph.2020.05.003] [PMID]
15. Rensen PC. Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise. Current Opinion in Pharmacology. 2020;52:1-9. [DOI:10.1016/j.coph.2020.05.003] [PMID]
16. Fujiwara Y, Eguchi S, Murayama H, Takahashi Y, Toda M, Imai K, Tsuda K. Relationship between diet/exercise and pharmacotherapy to enhance the GLP‐1 levels in type 2 diabetes. Endocrinology, Diabetes Metabolism. 2019;2(3):e00068. [DOI:10.1002/edm2.68] [PMID] [PMCID]
17. Drucker DJ, Jin T, Asa SL, Young TA, Brubaker PL. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol. 1994;8(12):1646-55.
https://doi.org/10.1210/me.8.12.1646 [DOI:10.1210/mend.8.12.7535893] [PMID]
18. Lan H, Lin H, Wang C, Wright M, Xu S, Kang L, et al. Agonists at GPR119 mediate secretion of GLP‐1 from mouse enteroendocrine cells through glucose‐independent pathways. Br J Pharmacol. 2012;165(8):2799-807. [DOI:10.1111/j.1476-5381.2011.01754.x] [PMID] [PMCID]
19. Akbarpour M, Fathollahi Shoorabeh F, Mardani M, Amini Majd F. Effects of Eight Weeks of Resistance Training and Consumption of Pomegranate on GLP-1, DPP-4 and Glycemic Statuses in Women with Type 2 Diabetes: A Randomized Controlled Trial. Nutrition Food Sciences Research. 2021;8(1):5-10.
20. Nejati R, Attarzadeh Hosseini SR, Bijeh N, Raouf Saeb A. The effects of twelve weeks of combined exercises on GLP-1 and insulin resistance in women with type 2 diabetes. Journal of Shahid Sadoughi University of Medical Sciences. 2019;27(1):1187-201. [DOI:10.18502/ssu.v27i1.877]
21. Sonoda N, Imamura T, Yoshizaki T, Babendure JL, Lu JC, Olefsky JM. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci U S A. 2008;105(18):6614-9. [DOI:10.1073/pnas.0710402105] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
